Somerville has become the first community in Massachusetts to take a step toward decriminalizing entheogenic plants. The council conducted a vote to pass a resolution that advocated for the decriminalization of entheogenic plants, with the results being unanimous.
The measure stated that Somerville employees, including police officers and officials from other agencies, should not utilize the city’s resources to help in enforcing laws against the possession and use of entheogenic plants by adults. However, the measure does not permit driving while under the influence of the said substances nor does it allow the commercial sale of the entheogens.
One of the sponsors of the measure, Councilor Jesse Clingan, stated that passing the resolution was another tool in the tool box the council has available to assist with many of the challenges that are impacting the society today.
Emerging research conducted on psychedelics has demonstrated the potential that these substances possess and how they can be used to treat various substance-use disorders and mental-health conditions. This is despite critics stating that there is still not enough evidence to help researchers fully comprehend the side effects of these hallucinogens, particularly when administered to individuals with severe physical and mental ailments.
Under federal law, it remains illegal to possess or cultivate hallucinogenic mushrooms without a special license issued by the Drug Enforcement Administration.
Residents of Somerville from various advocacy groups such as the Heroic Hearts Project, Decriminalize Nature Massachusetts and the Bay Staters of Natural Medicine had earlier sent a letter to the city council mentioning various studies that demonstrated the benefits of psychedelics. The letter also cited eight state legislators who were committed to exploring more on how controlled substances could be treated as a public health issue, in addition to naming other states and cities that had decriminalized psychedelic plants.
The letter sent to the city also explained that decriminalization represented a significant step forward not only for criminal justice but also for public health, given that the community was addressing suicide, depression and peak rates of opioid abuse. This was followed by an explanation detailing how psilocybin mushrooms, designated breakthrough therapy by the FDA, and other natural psychedelics were extremely effective in the treatment of these illnesses.
The measure not only centers on psychedelics but also cites all controlled substances, stating that the policy of the city of Somerville on arresting adults for either possessing or using controlled substances shall be among the lowest priority of law enforcement for the city.
Across the U.S. border in Canada, Pure Extracts technologies Corp. (CSE: PULL) (OTC: PRXTF) is poised to benefit fully from the resurgent interest in psychedelics and functional mushrooms. The company has a strong leadership team, some of whom have more than 30 years of industry experience, to guide the company on its journey to success in this evolving industry.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
